Literature DB >> 28604345

Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time.

Svetlana I Nihtyanova1, Christopher P Denton2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28604345     DOI: 10.3899/jrheum.170055

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

Review 1.  Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen.

Authors:  Maria-Grazia Lazzaroni; Paolo Airò
Journal:  J Scleroderma Relat Disord       Date:  2018-07-13

2.  Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials.

Authors:  David Roofeh; Oliver Distler; Yannick Allanore; Christopher P Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-03-05

Review 3.  Treatment for systemic sclerosis-associated interstitial lung disease.

Authors:  David Roofeh; Alain Lescoat; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2021-05-01       Impact factor: 4.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.